mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.01 |
mRNA |
MK 1775 |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.02 |
mRNA |
BIRB 0796 |
GDSC1000 |
pan-cancer |
AAC |
-0.088 |
0.02 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.02 |
mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.02 |
mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.02 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.02 |
mRNA |
piperlongumine |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.02 |
mRNA |
Sunitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.02 |
mRNA |
CR-1-31B |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.02 |